About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT05204823

Evaluation of the Glycemic Index in 4 Dairy Beverages.

The objective of the study is to evaluate the glycemic index and glycemic load of 4 chocolate milk drinks.

Lead sponsor: Universidad Católica San Antonio de Murcia•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Universidad Católica San Antonio de Murcia

Subjects will make a total of 5 visits. Four visits where they will drink a chocolate milkshake at each visit. In the other visit they will take glucose, as a comparator product. Due to the low amount of sugars in the shakes, subjects will drink the equivalent of 25g of glucose. At each visit subjects will have to come fasting, and samples will be collected at 9 different times.

Age

20 - 35 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Subjects of both sexes (10 men and 10 women).
•Subjects aged between 20 and 35 years.
•Subjects with a body mass index between 20 and 25 kg/m2.

Exclusion Criteria

•Subjects suffering from diabetes mellitus or any chronic disease.
•Subjects with medical problems or a diagnosed psychiatric disorder.
•Subjects with alcohol abuse or excessive alcohol consumption (\>3 glasses of wine or beer/day).
•Subjects consuming any pharmacological medication that may affect memory.
•Participation in another clinical trial in the three months prior to the study.
•Unwillingness or inability to comply with clinical trial procedures.
•Subjects whose condition does not make them eligible for the study according to the investigator's criteria.
•Pregnant or lactating women.

Related studies

Lutein, Zeaxathin, and Fish Oil Supplementation

NCT06489873 · Cognitive Performance, Age-Related Macular Degeneration, and more

Enrolling By InvitationNA

Effects of Long-Duration Spaceflight on General and Spatial Cognition and Its Neural Basis

NCT04856410 · Brain Structure, Cognitive Performance

Active Not Recruiting

Post-stroke Cognitive Impairment

NCT05653141 · First-ever Ischemic Stroke, Cognitive Performance

Acute Effects of Creatine and L-Arginine Co-Supplementation on Anaerobic and Cognitive Performance in Recreationally Active Males

NCT07548541 · Anaerobic Performance, Cognitive Performance, and more

Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn

NCT07427654 · Glycemic Index, Glycemic Load

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 21, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment20

Start dateDec 2021

Last updatedJun 21, 2022

Condition

Glycemic Index Cognitive Performance

Locations shown

Catholic University of Murcia

Murcia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 21, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions